Search
Give yourself the perfect gift: Trim your holiday stress: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-holiday-stress-news-tip.html
Experts at UT Southwestern Medical Center say there are ways to manage stress and make your holidays much more enjoyable – and they start with adjusting your expectations, which will help relieve the pressure you put on yourself to achieve perfection.
Personal approach reduces opioids after cesarean deliveries: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-opioids-prescribed-after-c-section.html
Tailoring prescriptions individually to a patient’s needs after cesarean delivery can decrease opioid use while successfully managing post-surgical pain, according to a new study by researchers at UT Southwestern Medical Center. The change in protocol, detailed in a study published in the American Journal of Obstetrics and Gynecology, lessened the number of opioids released into the community by more than 90,000 tablets per year.
Treat yourself to healthy eating habits for the holidays: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-healthy-eating-habits-for-the-holidays.html
Office parties and family dinners make eating healthy during the holiday season a challenge. But you can still enjoy your favorite treats while maintaining a balanced diet, according to nutrition experts at UT Southwestern Medical Center.
Traditional Chinese medicine reduces risk after heart attack: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-traditional-chinese-medicine-heart-attack.html
A traditional Chinese medicine whose name means “to open the network of the heart” reduced the risk of heart attacks, deaths, and other major cardiovascular complications for at least a year after a first heart attack, a study led by UT Southwestern Medical Center researchers shows.
Jinming Gao named fellow of the National Academy of Inventors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-gao-fellow-national-academy-inventors.html
Jinming Gao, Ph.D., Professor of Biomedical Engineering, Cell Biology, Otolaryngology – Head and Neck Surgery, and Pharmacology at UT Southwestern Medical Center, has been selected as a fellow of the National Academy of Inventors (NAI) in recognition of his efforts to develop innovative nanotechnology platforms to improve cancer diagnosis and treatment.
New Knowledge Commons to improve understanding of immune system: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-new-knowledge-commons-immune-system.html
UT Southwestern Medical Center will lead a multi-institution effort to gather and assimilate information on the billions of sequences employed by immune receptors of the adaptive immune system.
Combination therapy slows cognitive decline, research shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/oct-combination-therapy-cognitive-decline.html
A novel combination therapy slowed cognitive decline in elderly patients with a history of depression – a major risk factor for developing Alzheimer’s and other forms of dementia, a study led by UT Southwestern Medical Center’s new Chair and Professor of Psychiatry found.
Weekly insulin found safe, effective for Type 2 diabetes: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-weekly-insulin-found-safe.html
An experimental form of insulin administered just once a week was safe for patients with Type 2 diabetes and helped them maintain healthy blood sugar levels better than insulin injected daily, according to the results of a phase 3 clinical trial led by a UT Southwestern Medical Center researcher.
Drug developed by UTSW spinoff approved for metastatic kidney cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-metastatic-kidney-cancer-drug-spinoff.html
The U.S. Food & Drug Administration has expanded the approved use of belzutifan for treatment of metastatic kidney cancer, another milestone for the novel, first-in-class kidney cancer drug arising from scientific discoveries at UT Southwestern Medical Center.
UTSW Q&A: Experts talk about opioid abuse, risks, treatment: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/aug-q-a-opioid-abuse-risks-treatment.html
Overdose deaths from opioids, including prescription painkillers and synthetics like fentanyl, continue to rise. According to the Centers for Disease Control and Prevention, an estimated 187 people in the U.S. die every day of opioid overdoses, most involving illicit and dangerous versions of fentanyl.